Your session is about to expire
← Back to Search
ECG Monitor
Atrial fibrillation for Atrial Fibrillation
N/A
Waitlist Available
Led By Elaine WAN, MD
Research Sponsored by Withings
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
This trialtests a device to detect atrial fibrillation, an irregular heart rhythm, automatically.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Co-
Secondary outcome measures
Clinical Equivalence of ECG waveforms
Evaluation of the classification into heart rate subgroups
Heart Rate equivalence
Trial Design
2Treatment groups
Experimental Treatment
Group I: Normal Sinus RhythmExperimental Treatment1 Intervention
Group II: Atrial fibrillationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Electrocardiogram recording
2022
N/A
~1340
Find a Location
Who is running the clinical trial?
WithingsLead Sponsor
21 Previous Clinical Trials
4,333 Total Patients Enrolled
8 Trials studying Atrial Fibrillation
2,264 Patients Enrolled for Atrial Fibrillation
SyntactxNETWORK
22 Previous Clinical Trials
1,146,789 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
685 Patients Enrolled for Atrial Fibrillation
Elaine WAN, MDPrincipal InvestigatorColumbia University Irving Medical Center/ NewYork Presbyterian Hospital
1 Previous Clinical Trials
685 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
685 Patients Enrolled for Atrial Fibrillation
Share this study with friends
Copy Link
Messenger